Traws Pharma, Inc. · NASDAQ:TRAW

Orbimed Advisors LLC reported a 19.90% stake in Traws Pharma, Inc. (Schedule 13D/A)

Event Dec 31, 2024 · Filed Jan 29, 2025

Orbimed Advisors LLC reported a 19.90% stake in Traws Pharma, Inc., 760,824 shares, with active intent on Dec 31, 2024. Filed Jan 29, 2025 (Schedule 13D/A).

Stake
19.90%
Shares
760,824
Intent
Active
What changed
Stake changed
Filed together
2 holders

The filing in full

HolderStakeShares
ORBIMED ADVISORS LLC19.90%760,824
OrbiMed Capital GP VIII LLC19.90%760,824

Source

View original at SEC

Related